{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:50:17Z","timestamp":1772895017453,"version":"3.50.1"},"reference-count":41,"publisher":"Japan Atherosclerosis Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,5,1]]},"DOI":"10.5551\/jat.62807","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T22:12:10Z","timestamp":1621462330000},"page":"667-677","source":"Crossref","is-referenced-by-count":10,"title":["Genetic Analysis of Japanese Children Clinically Diagnosed with Familial Hypercholesterolemia"],"prefix":"10.5551","volume":"29","author":[{"given":"Keiko","family":"Nagahara","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Nishibukuro","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Ogiwara","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kento","family":"Ikegawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Tada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Internal Medicine. Kanazawa University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Yamagishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Internal Medicine. Kanazawa University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masa-aki","family":"Kawashiri","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Internal Medicine. Kanazawa University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Ochi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Adachi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazushige","family":"Dobashi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Showa University School of Medicine"},{"name":"Department of Pediatrics, School of Medicine, University of Yamanashi"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","unstructured":"1) Goldstein JL, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle I, eds. The Metabolic Basis of Inherited Disease. 6th ed. New York, NY: McGraw-Hill International Book Co; 1989: 1215-1250"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Innerarity TL, Weisgraber KH, Arnold KS, Mahley RW, Krauss RM, Vega GL, Grundy SM. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci U S A, 1987; 84: 6919-6923","DOI":"10.1073\/pnas.84.19.6919"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Abifadel M, Varret M, Rab\u00e8s JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D, Derr\u00e9 A, Vill\u00e9ger L, Farnier M, Beucler I, Bruckert E, Chambaz J, Chanu B, Lecerf JM, Luc G, Moulin P, Weissenbach J, Prat A, Krempf M, Junien C, Seidah NG, Boileau C. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet, 2003; 34: 154-156","DOI":"10.1038\/ng1161"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Bor\u00e9n J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AF, Stroes E, Taskinen MR, Tybj\u00e6rg-Hansen A; European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J, 2013; 34: 3478-3490a","DOI":"10.1093\/eurheartj\/eht273"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Mabuchi H. Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan. J Atheroscler Thromb, 2017; 24: 189-207","DOI":"10.5551\/jat.RV16008"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Yu W, Nohara A, Higashikata T, Lu H, Inazu A, Mabuchi H. Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population. Atherosclerosis, 2002; 165: 335-342","DOI":"10.1016\/S0021-9150(02)00249-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Hori M, Ohta N, Takahashi A, Masuda H, Isoda R, Yamamoto S, Son C, Ogura M, Hosoda K, Miyamoto Y, Harada-Shiba M. Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients. Atherosclerosis, 2019; 289: 101-108","DOI":"10.1016\/j.atherosclerosis.2019.08.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Wiegman A, de Groot E, Hutten BA, Rodenburg J, Gort J, Bakker HD, Sijbrands EJ, Kastelein JJ. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia. Lancet, 2004; 363: 369-370","DOI":"10.1016\/S0140-6736(04)15467-6"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Harada-Shiba M, Ohta T, Ohtake A, Ogura M, Dobashi K, Nohara A, Yamashita S, Yokote K, Joint Working Group by Japan Pediatric Society and Japan Atherosclerosis Society for Making Guidance of Pediatric Familial Hypercholesterolemia. Guidance for Pediatric Familial Hypercholesterolemia 2017. J Atheroscler Thromb, 2018; 25: 539-553","DOI":"10.5551\/jat.CR002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Dobashi K. Changes in Serum Cholesterol in Childhood and its Tracking to Adulthood. J Atheroscler Thromb, 2022; 29: 5-7","DOI":"10.5551\/jat.ED163"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Dobashi K. Evaluation of Obesity in School-Age Children. J Atheroscler Thromb, 2016; 23: 32-38","DOI":"10.5551\/jat.29397"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Tada H, Kawashiri MA, Nomura A, Teramoto R, Hosomichi K, Nohara A, Inazu A, Mabuchi H, Tajima A, Yamagishi M. Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease. J Clin Lipidol, 2018; 12: 1436-1444","DOI":"10.1016\/j.jacl.2018.08.006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Talmud PJ, Shah S, Whittall R, Futema M, Howard P, Cooper JA, Harrison SC, Li K, Drenos F, Karpe F, Neil HA, Descamps OS, Langenberg C, Lench N, Kivimaki M, Whittaker J, Hingorani AD, Kumari M, Humphries SE. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study. Lancet, 2013; 381: 1293-1301","DOI":"10.1016\/S0140-6736(12)62127-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, Keavney B, Collins R, Wiman B, de Faire U, Danesh J. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA, 2007; 298: 1300-1311","DOI":"10.1001\/jama.298.11.1300"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Harada-Shiba M, Takagi A, Miyamoto Y, Tsushima M, Ikeda Y, Yokoyama S, Yamamoto A. Clinical features and genetic analysis of autosomal recessive hypercholesterolemia. J Clin Endocrinol Metab, 2003; 88: 2541-2547","DOI":"10.1210\/jc.2002-021487"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Tada H, Kawashiri MA, Ohtani R, Noguchi T, Nakanishi C, Konno T, Hayashi K, Nohara A, Inazu A, Kobayashi J, Mabuchi H, Yamagishi M. A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene. Atherosclerosis, 2011; 219: 663-666","DOI":"10.1016\/j.atherosclerosis.2011.08.004"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, Hobbs HH. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest, 2002; 110: 671-680","DOI":"10.1172\/JCI0216001"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Lamiquiz-Moneo I, Baila-Rueda L, Bea AM, Mateo-Gallego R, P\u00e9rez-Calahorra S, Marco-Bened\u00ed V, Mart\u00edn-Navarro A, Ros E, Cof\u00e1n M, Rodr\u00edguez-Rey JC, Pocovi M, Cenarro A, Civeira F. ABCG5\/G8 gene is associated with hypercholesterolemias without mutation in candidate genes and noncholesterol sterols. J Clin Lipidol, 2017; 11: 1432-1440","DOI":"10.1016\/j.jacl.2017.09.005"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, Maglott DR. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res, 2014; 42: D980-D985","DOI":"10.1093\/nar\/gkt1113"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Mabuchi H, Nohara A, Noguchi T, Kobayashi J, Kawashiri MA, Inoue T, Mori M, Tada H, Nakanishi C, Yagi K, Yamagishi M, Ueda K, Takegoshi T, Miyamoto S, Inazu A, Koizumi J; Hokuriku FH Study Group. Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein16convertase subtilisin\/kexin type 9 (PCSK9) gain-of-function mutation. Atherosclerosis, 2014; 236: 54-61","DOI":"10.1016\/j.atherosclerosis.2014.06.005"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Maruyama T, Miyake Y, Tajima S, Harada-Shiba M, Yamamura T, Tsushima M, Kishino B, Horiguchi Y, Funahashi T, Matsuzawa Y, Yamamoto A. Common mutations in the low-density-lipoprotein-receptor gene causing familial hypercholesterolemia in the Japanese population. Arterioscler Thromb Vasc Biol, 1995; 15: 1713-1718","DOI":"10.1161\/01.ATV.15.10.1713"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Leitersdorf E, Tobin EJ, Davignon J, Hobbs HH. Common low-density lipoprotein receptor mutations in the French Canadian population.J Clin Invest, 1990; 85: 1014-1023","DOI":"10.1172\/JCI114531"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Chmara M, Wasag B, Zuk M, Kubalska J, Wegrzyn A, Bednarska-Makaruk M, Pronicka E, Wehr H, Defesche JC, Rynkiewicz A, Limon J. Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutations. J Appl Genet, 2010; 51: 95-106","DOI":"10.1007\/BF03195716"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Hattori H, Nagano M, Iwata F, Homma Y, Egashira T, Okada T. Identification of recurrent and novel mutations in the LDL receptor gene in Japanese familial hypercholesterolemia. Hum Mutat, 1999; 14: 87","DOI":"10.1002\/(SICI)1098-1004(1999)14:1<87::AID-HUMU13>3.0.CO;2-Q"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Jensen HK, Jensen LG, Hansen PS, Faergeman O, Gregersen N. Two point mutations (313 + 1G --\uff1e A and 313 + 1G --\uff1e T) in the splice donor site of intron 3 of the low-density lipoprotein receptor gene are associated with familial hypercholesterolemia. Hum Mutat, 1996; 7: 269-271","DOI":"10.1002\/(SICI)1098-1004(1996)7:3<269::AID-HUMU13>3.0.CO;2-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Yamakawa-Kobayashi K, Kobayashi T, Saku K, Arakawa K, Hamaguchi H. Two novel frameshift mutations associated with the presence of direct repeats of the LDL receptor gene in familial hypercholesterolemia. Hum Genet, 1993; 92: 331-335","DOI":"10.1007\/BF01247329"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Nagahara K, Hachiya R, Tada H, Okada H, Yamagishi M, Dobashi K, Mizuno K, Hasegawa Y. A Japanese case of familial hypercholesterolemia with a novel mutation in the LDLR gene. Clin Pediatr Endocrinol, 2019; 28: 19-22","DOI":"10.1297\/cpe.28.19"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Zhou Y, M\u00e4gi R, Milani L, Lauschke VM. Lauschke Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk. J Lipid Res, 2018; 59: 1987-2000","DOI":"10.1194\/jlr.P086710"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Sadananda SN, Foo JN, Toh MT, Cermakova L, Trigueros-Motos L, Chan T, Liany H, Collins JA, Gerami S, Singaraja RR, Hayden MR, Francis GA, Frohlich J, Khor CC, Brunham LR. Targeted next-generation sequencing to diagnose disorders of HDL cholesterol. J Lipid Res, 2015; 56: 1993-2001","DOI":"10.1194\/jlr.P058891"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Takahashi K, Jiang XC, Sakai N, Yamashita S, Hirano K, Bujo H, Yamazaki H, Kusunoki J, Miura T, Kussie P. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J Clin Invest, 1993; 92: 2060-2064","DOI":"10.1172\/JCI116802"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Klan\u010dar G, Gro\u0161elj U, Kova\u010d J, Bratani\u010d N, Bratina N, Trebu\u0161ak Podkraj\u0161ek K, Battelino T. Universal Screening for Familial Hypercholesterolemia in Children. J Am Coll Cardiol, 2015; 66: 1250-1257","DOI":"10.1016\/j.jacc.2015.07.017"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Fairoozy RH, Futema M, Vakili R, Abbaszadegan MR, Hosseini S, Aminzadeh M, Zaeri H, Mobini M, Humphries SE, Sahebkar A. The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population. Sci Rep, 2017; 7: 17087","DOI":"10.1038\/s41598-017-17181-9"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Minicocci I, Pozzessere S, Prisco C, Montali A, di Costanzo A, Martino E, Martino F, Arca M. Analysis of Children and Adolescents with Familial Hypercholesterolemia. J Pediatr, 2017; 183: 100-107","DOI":"10.1016\/j.jpeds.2016.12.075"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Stitziel NO, Peloso GM, Abifadel M, Cefalu AB, Fouchier S, Motazacker MM, Tada H, Larach DB, Awan Z, Haller JF, Pullinger CR, Varret M, Rab\u00e8s JP, Noto D, Tarugi P, Kawashiri MA, Nohara A, Yamagishi M, Risman M, Deo R, Ruel I, Shendure J, Nickerson DA, Wilson JG, Rich SS, Gupta N, Farlow DN, Neale BM, Daly MJ, Kane JP, Freeman MW, Genest J, Rader DJ, Mabuchi H, Kastelein JJ, Hovingh GK, Averna MR, Gabriel S, Boileau C, Kathiresan S. Exome sequencing in suspected monogenic dyslipidemias. Cir Cardiovasc Genet, 2015; 8: 343-350","DOI":"10.1161\/CIRCGENETICS.114.000776"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Tada H, Okada H, Nomura A, Yashiro S, Nohara A, Ishigaki Y, Takamura M, Kawashiri MA. Rare and deleterious mutations in ABCG5\/ABCG8 genes contribute to mimicking and worsening of familial hypercholesterolemia Phenotype. Circ J, 2019; 83: 1917-1924","DOI":"10.1253\/circj.CJ-19-0317"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Nomura A, Emdin CA, Won HH, Peloso GM, Natarajan P, Ardissino D, Danesh J, Schunkert H, Correa A, Bown MJ, Samani NJ, Erdmann J, McPherson R, Watkins H, Saleheen D, Elosua R, Kawashiri MA, Tada H, Gupta N, Shah SH, Rader DJ, Gabriel S, Khera AV, Kathiresan S. Heterozygous ABCG5 gene deficiency and risk of coronary artery disease. Circ Genom Precis Med, 2020; 13: 417-423","DOI":"10.1161\/CIRCGEN.119.002871"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Fouchier SW, Dallinga-Thie GM, Meijers JC, Zelcer N, Kastelein JJ, Defesche JC, Hovingh GK. Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia. Circ Res, 2014; 115: 525-555","DOI":"10.1161\/CIRCRESAHA.115.304660"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Khera AV, Won HH, Peloso GM, Lawson KS, Bartz TM, Deng X, van Leeuwen EM, Natarajan P, Emdin CA, Bick AG, Morrison AC, Brody JA, Gupta N, Nomura A, Kessler T, Duga S, Bis JC, van Duijn CM, Cupples LA, Psaty B, Rader DJ, Danesh J, Schunkert H, McPherson R, Farrall M, Watkins H, Lander E, Wilson JG, Correa A, Boerwinkle E, Merlini PA, Ardissino D, Saleheen D, Gabriel S, Kathiresan S. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. J Am Coll Cardiol, 2016; 67: 2578-2589","DOI":"10.1016\/j.jacc.2016.03.520"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Wang H, Yang H, Liu Z, Cui K, Zhang Y, Zhang Y, Zhao K, Yin K, Li W, Zhou Z. Targeted Genetic Analysis in a Chinese Cohort of 208 Patients Related to Familial Hypercholesterolemia. J Atheroscler Thromb, 2020; 27: 1288-1298","DOI":"10.5551\/jat.54593"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Johansen AK, Bogsrud MP, Roeters van Lennep J, Narverud I, Langslet G, Retterst\u00f8l K, Holven KB. Long term follow-up of children with familial hypercholesterolemia and relatively normal LDL-cholesterol at diagnosis. J Clin Lipidol, 2021; 15: 375-378","DOI":"10.1016\/j.jacl.2021.01.007"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Makino H, Koezuka R, Tamanaha T, Ogura M, Matsuki K, Hosoda K, Harada-Shiba M. Familial Hypercholesterolemia and Lipoprotein Apheresis. J Atheroscler Thromb, 2019; 26: 679-687","DOI":"10.5551\/jat.RV17033"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/5\/29_62807\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:29:30Z","timestamp":1715232570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/5\/29_62807\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.62807","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,1]]},"article-number":"62807"}}